Project Grant R43HD118859

Award Date 5/20/25
Completion Date 11/30/25
Dollars Obligated $328K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $384,923 to Lumina Medical LLC for the development of an innovative and affordable vaginal dilation device. The device aims to significantly improve pain management for patients with chronic pelvic floor disorders, including post-menopausal vaginal atrophy, vaginal stenosis, and others affecting over 25 million women...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $384,973 to support the development of an intravaginal, wearable medical device called "Violet" to treat women with high tone pelvic floor dysfunction (HTPFD). The device is designed to deliver both intravaginal electrical stimulation (IES) and focal muscle vibration (FMV) to...
This Project Grant award from the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $1,514,498 to Madorra Inc., a for-profit small business, to develop and test an at-home, non-hormonal medical device to treat vulvovaginal atrophy (VVA) in peri- and post-menopausal women, including breast cancer survivors. The Madorra Therapy System uses therapeutic ultrasound to increase vaginal blood flow and...
The National Institute of Child Health and Human Development (NICHD) awarded a $474,946 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the University of Health Sciences and Pharmacy in St. Louis to develop a novel, female-initiated, non-hormonal contraceptive device. The project aims to create a multipurpose vaginal delivery system that combines a bioresponsive polymer fiber mat and an acid-buffering, mucoadhesive gel to fortify natural...
The National Institute of Child Health and Human Development (NICHD) awarded a $343,510 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to Theranova LLC, a veteran-owned medical device company based in San Francisco, CA. The grant supports the development and pilot evaluation of the SOLESTIM neuromodulation system, a portable, non-invasive device designed to treat dysmenorrhea (menstrual cramps) through plantar nerve stimulation. The...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop a bioadhesive vaginal film that can provide extended release of contraceptive and antiviral monoclonal antibodies. The $518,754 award, with a performance period from February 1, 2025 to January 31, 2026, will fund research by the Magee-Womens Research Institute and Foundation, with sub-awards to...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $383,114 to Venova Technologies Inc., a women-led and minority-led medical device startup company, to advance the development of their novel, non-hormonal, long-acting female contraceptive device. The funding will enable Venova to continue improving and de-risking their innovative contraceptive...
This $1,459,876 Project Grant, awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to develop a bioinspired composite scaffold for the regeneration of pubovisceral muscle enthesis (PVME) injuries that commonly occur during childbirth. The primary awardee, Magee-Womens Research Institute and Foundation, will collaborate with researchers at Columbia University and...
This $384,558 Project Grant award from the National Institutes of Health's (NIH) Child Health and Human Development Extramural Research program (CFDA 93.865) supports the development and evaluation of the "SenseWand" - a wireless pelvic floor diagnostic system (device and app) to assess pelvic floor muscle health using Electrical Impedance Myography (EIM). The recipient, Bold Type LLC, is a minority-owned, small disadvantaged business developing innovative medical devices and...
This Project Grant award, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to characterize the multiscale mechanisms of pregnancy-induced remodeling of pelvic floor muscles (PFMs) in order to promote understanding of vaginal birth biomechanics and injury prevention. The $117,959 award, effective from August 1, 2024 to July 31, 2026, will fund experimental and computational...

This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $328,496 to Pelva Health Corporation to develop a non-pharmaceutical hydrogel film and applicator delivery system to help mitigate pain experienced during sexual intercourse by women with vulvodynia and vestibulodynia. The goal is to create a solution that can immediately provide pain relief without the negative consequences of commonly prescribed pharmaceuticals. The award period runs from May 20, 2025 to November 30, 2025. If successful, this technology has the potential to be the first FDA-indicated device for these gynecological pain conditions.

Generated 6/17/25, 5:58 AM